Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vanessa Almendro

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Cancer Discovery|May 26, 2012
Evolutionary pathways in BRCA1-associated breast tumorsFilipe C Martins, Subhajyoti De, Vanessa Almendro, et al.
Nature Genetics|August 25, 2015
In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancerMichalina Janiszewska, Lin Liu, Vanessa Almendro, et al.
Cancer Research|September 14, 2013
Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancerSusana Garcia-Recio, Gemma Fuster, Patricia Fernandez-Nogueira, et al.
Cytotherapy|July 5, 2025
Advancing gene-editing platforms to improve the viability of rare-disease therapeutics: key insights from a 2024 Scientific Exchange hosted by ARM, ISCT, and DanaherFyodor Urnov, Sadik Kassim, Kiran Musunuru, et al.
Breast Cancer Research : BCR|July 6, 2018
Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosisArantzazu Zubeldia-Plazaola, Leire Recalde-Percaz, Núria Moragas, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2010
8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYCNasim Ahmadiyeh, Mark M Pomerantz, Chiara Grisanzio, et al.
Cell Reports|January 28, 2014
Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversityVanessa Almendro, Yu-Kang Cheng, Amanda Randles, et al.
Cancer Cell|June 18, 2014
JARID1B is a luminal lineage-driving oncogene in breast cancerShoji Yamamoto, Zhenhua Wu, Hege G Russnes, et al.
The Journal of Clinical Investigation|June 3, 2011
The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumorsLauren L C Marotta, Vanessa Almendro, Andriy Marusyk, et al.
Cancer Research|November 21, 2022
JAK-STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell StatesLaura E Stevens, Guillermo Peluffo, Xintao Qiu, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Cancer Discovery|May 26, 2012
Evolutionary pathways in BRCA1-associated breast tumorsFilipe C Martins, Subhajyoti De, Vanessa Almendro, et al.
Nature Genetics|August 25, 2015
In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancerMichalina Janiszewska, Lin Liu, Vanessa Almendro, et al.
Cancer Research|September 14, 2013
Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancerSusana Garcia-Recio, Gemma Fuster, Patricia Fernandez-Nogueira, et al.
Cytotherapy|July 5, 2025
Advancing gene-editing platforms to improve the viability of rare-disease therapeutics: key insights from a 2024 Scientific Exchange hosted by ARM, ISCT, and DanaherFyodor Urnov, Sadik Kassim, Kiran Musunuru, et al.
Breast Cancer Research : BCR|July 6, 2018
Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosisArantzazu Zubeldia-Plazaola, Leire Recalde-Percaz, Núria Moragas, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2010
8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYCNasim Ahmadiyeh, Mark M Pomerantz, Chiara Grisanzio, et al.
Cell Reports|January 28, 2014
Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversityVanessa Almendro, Yu-Kang Cheng, Amanda Randles, et al.
Cancer Cell|June 18, 2014
JARID1B is a luminal lineage-driving oncogene in breast cancerShoji Yamamoto, Zhenhua Wu, Hege G Russnes, et al.
The Journal of Clinical Investigation|June 3, 2011
The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumorsLauren L C Marotta, Vanessa Almendro, Andriy Marusyk, et al.
Cancer Research|November 21, 2022
JAK-STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell StatesLaura E Stevens, Guillermo Peluffo, Xintao Qiu, et al.
Pageof 6